Code Cart Crisis: Anatomy Of An Emergency Drug Shortage
Executive Summary
How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.
You may also be interested in...
Global Supply Chain Scrutiny And Investment In Domestic Alternatives For US Drug Shortages
Pharmaceutical supply chains may grow less efficient and less risk prone as US government gets more involved to ensure availability of pandemic and essential medicines. But what about pediatric oncology medicines and other treatments that save lives even though they may not be considered essential?
Public-Private Consortium To Strengthen Essential Medicines Supply Under White House Initiative
President Biden’s 100-day plan relies on Defense Production Act authorities to increase resilience of critical domestic pharmaceutical supplies.
To Lower Drug Prices, Look At Generic Industry Health Rather Than FDA, Woodcock Says
US FDA can encourage and increase competition, but cannot force generic companies to enter markets deemed unprofitable, CDER director says.